[1] ZHAO J，ZHAO H M，LI R T，et al. Outcome of

multimodal MRI-guided intravenous thrombolysis in

patients with stroke with unknown time of onset[J].

Stroke Vasc Neurol，2019，4（1）：3-7.

[2] BAI Q K，ZHAO Z G，LU L J，et al. Treating

ischemic stroke with intravenous tPA beyond 4.5

hours under the guidance of a MRI DWI/T2WI

mismatch was safe and effective[J] Stroke Vasc

Neurol，2019，4（1）：8-13.

[3] KRANZ P G，EASTWOOD J D. Does diffusionweighted

imaging represent the ischemic core? An

evidence-based systematic review[J]. AJNR Am J

Neuroradiol，2009，30（6）：1206-1212.

[4] KIDWELL C S，ALGER J R，SAVER J L. Beyond

mismatch：evolving paradigms in imaging the

ischemic penumbra with multimodal magnetic

resonance imaging[J]. Stroke，2003，34（11）：2729-

2735.

[5] CAMPBELL B C，MITCHELL P J，KLEINIG T J，

et al. Endovascular therapy for ischemic stroke with

perfusion-imaging selection[J]. N Engl J Med，2015，

372（11）：1009-1018.

[6] NOGUEIRA R G，JADHAV A P，HAUSSEN D C，

et al. Thrombectomy 6 to 24 hours after stroke with

a mismatch between deficit and infarct[J]. N Engl J

Med，2018，378（1）：11-21.

[7] NAGAI K，AOKI J，SAKAMOTO Y，et al. About

30% of wake-up stroke patients may be candidate for

the tPA therapy using Negative-FLAIR as a "tissue

clock"[J/OL]. J Neurol Sci，2017，382：101-104[2019-

12-01]. https：//doi.org/10.1016/j.jns.2017.09.042.

[8] MLYNASH M，LANSBERG M G，DE SILVA D A，

et al. Refining the definition of the malignant profile：

insights from the DEFUSE-EPITHET pooled data

set[J]. Stroke，2011，42（5）：1270-1275.

[9] 吴川杰，马青峰，陈健，等. 用组织窗代替传统时间

窗指导急性脑梗死的再灌注治疗[J]. 中国卒中杂志，

2018，13（8）：847-852.

[10] DE MARGERIE-MELLON C，TURC G，

TISSERAND M，et al. Can DWI-ASPECTS

substitute for lesion volume in acute stroke?[J].

Stroke，2013，44（12）：3565-3567.